trial · primary record
Bleomycin Sulfate
Ann Arbor Stage IIB Hodgkin Lymphoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2027-10-14 |
| Primary endpoint | Event Free Survival (EFS), Where Events Include Disease Progression or Relapse, Second Malignancy, or Death |
| Registry ID | NCT02166463 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:35.469Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02166463
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.